Hemenway Trust Co LLC - NOVOZYMES A S DKK 2.0 ownership

NOVOZYMES A S DKK 2.0's ticker is and the CUSIP is B798FW902. A total of 8 filers reported holding NOVOZYMES A S DKK 2.0 in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.5%.

Quarter-by-quarter ownership
Hemenway Trust Co LLC ownership history of NOVOZYMES A S DKK 2.0
ValueSharesWeighting
Q3 2023$235,018
-11.6%
5,838
+2.0%
0.02%
-3.8%
Q2 2023$265,806
+11.2%
5,723
+21.9%
0.03%
+4.0%
Q1 2023$239,049
-56.7%
4,695
-57.1%
0.02%
-59.0%
Q4 2022$552,697
-36.8%
10,945
-36.9%
0.06%
-40.8%
Q3 2022$874,000
-30.6%
17,335
-17.6%
0.10%
-28.0%
Q2 2022$1,260,000
-53.2%
21,035
-46.3%
0.14%
-44.8%
Q1 2022$2,691,000
-54.5%
39,160
-45.7%
0.26%
-51.9%
Q4 2021$5,912,000
-10.5%
72,121
-25.4%
0.54%
-19.5%
Q3 2021$6,609,000
-34.0%
96,725
-27.3%
0.67%
-33.8%
Q2 2021$10,012,000
-23.1%
133,123
-34.7%
1.01%
-29.1%
Q1 2021$13,016,000
+9.9%
203,795
-1.5%
1.42%
+5.0%
Q4 2020$11,844,000
-9.2%
206,884
-0.4%
1.36%
-20.1%
Q3 2020$13,048,000
+9.4%
207,692
+0.4%
1.70%
+2.3%
Q2 2020$11,927,000
+27.5%
206,922
+0.8%
1.66%
+4.8%
Q1 2020$9,357,000
-4.5%
205,377
+2.3%
1.58%
+12.3%
Q4 2019$9,798,000
+15.2%
200,770
-1.0%
1.41%
+5.7%
Q3 2019$8,506,000
-9.1%
202,841
+0.8%
1.33%
-7.8%
Q2 2019$9,357,000
+1.6%
201,231
+0.2%
1.44%
-2.7%
Q1 2019$9,213,000
+15.8%
200,843
+12.4%
1.48%
-8.6%
Q4 2018$7,956,000
-24.9%
178,628
-7.7%
1.62%
-9.0%
Q3 2018$10,596,000
+8.9%
193,628
+0.8%
1.78%
-0.6%
Q2 2018$9,730,000
-1.8%
192,067
-0.1%
1.80%
-4.8%
Q1 2018$9,913,000
-11.2%
192,307
-1.9%
1.89%
-11.3%
Q4 2017$11,163,000
+10.7%
195,948
-0.5%
2.13%
+1.0%
Q3 2017$10,085,000
+18.0%
196,925
+0.8%
2.10%
+10.8%
Q2 2017$8,546,000
+13.5%
195,280
+2.8%
1.90%
+9.6%
Q1 2017$7,530,000
+20.3%
189,990
+4.7%
1.73%
+9.9%
Q4 2016$6,258,000
-19.1%
181,515
+3.2%
1.58%
-18.5%
Q3 2016$7,735,000
-7.4%
175,865
+1.3%
1.94%
-11.1%
Q2 2016$8,354,000
+9.4%
173,690
+2.2%
2.18%
+5.6%
Q1 2016$7,638,000
-4.5%
169,890
+2.2%
2.06%
-2.3%
Q4 2015$8,000,000
+13.1%
166,170
+2.3%
2.11%
+8.0%
Q3 2015$7,075,000
-5.6%
162,395
+3.0%
1.95%
+1.6%
Q2 2015$7,494,000
+6.1%
157,645
+2.2%
1.92%
+4.0%
Q1 2015$7,060,000
+9.1%
154,260
+0.6%
1.85%
-4.4%
Q4 2014$6,474,000
-0.9%
153,370
+1.8%
1.94%
-5.3%
Q3 2014$6,536,000
-13.4%
150,640
+0.1%
2.04%
-10.7%
Q2 2014$7,548,000
+14.6%
150,490
+0.5%
2.29%
+10.5%
Q1 2014$6,585,000
+4.2%
149,760
+0.1%
2.07%
+2.3%
Q4 2013$6,317,000
+10.3%
149,6600.0%2.03%
-5.1%
Q3 2013$5,725,000
+19.9%
149,660
+0.3%
2.13%
+4.8%
Q2 2013$4,775,000
-5.3%
149,200
+0.4%
2.04%
-4.5%
Q1 2013$5,040,000148,6502.13%
Other shareholders
NOVOZYMES A S DKK 2.0 shareholders Q4 2020
NameSharesValueWeighting ↓
SOMERVILLE KURT F 201,293$11,524,0001.88%
Broderick Brian C 103,399$5,920,0001.76%
PUZO MICHAEL J 87,630$5,016,0001.64%
Page Arthur B 37,110$2,124,0001.60%
Kidder Stephen W 82,525$4,725,0001.57%
Dempze Nancy E 26,868$1,538,0001.41%
Hemenway Trust Co LLC 206,884$11,844,0001.36%
Notis-McConarty Edward 32,876$1,882,0000.77%
View complete list of NOVOZYMES A S DKK 2.0 shareholders